Otolith Labs, maker of a headband wearable that aims to treat chronic vertigo, raised $20 million in a Series A round led by Morningside Ventures. The company announced last year the device had ...
WASHINGTON--(BUSINESS WIRE)--Otolith Labs, a medical technology company developing noninvasive wearable medical devices for the treatment of vestibular disorders, today announced the closing of a $20 ...
Otolith Labs’ noninvasiveVESTIBULAR SYSTEM MASKING (nVSM) technology is designed to provide acute treatment for vestibulogenic vertigo. The headband device (see photo above) applies localized ...
Otolith Sound Inc. closed a $20 million series A financing round led by Morningside Ventures for its treatment for chronic vertigo. The latest funding follows a $3.3 million seed financing round and ...
WASHINGTON--(BUSINESS WIRE)--Otolith Labs, a medical technology company developing non-invasive wearable medical devices for the treatment of vestibular disorders, appointed Kevin Franck, PhD, MBA as ...
WASHINGTON, Feb. 13, 2025 /PRNewswire/ -- Otolith Labs, a medical technology company developing prescription medical devices for the treatment of vestibular disorders, announced results from an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results